gemcitabine has been researched along with leptin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, G; Fan, Z; Ma, L; Wang, H | 1 |
| Chu, PY; Lai, HY; Liang, HY; Liu, YB; Shen, WJ; Wang, JM; Wang, WJ; Zhang, F | 1 |
2 other study(ies) available for gemcitabine and leptin
| Article | Year |
|---|---|
Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Factor 6; Leptin; Male; Mice, Nude; MicroRNAs; Pancreatic Neoplasms; Up-Regulation | 2019 |
MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer.
Topics: Adipocytes; Animals; Antimetabolites, Antineoplastic; Apoptosis Regulatory Proteins; CCAAT-Enhancer-Binding Protein-delta; Deoxycytidine; Drug Discovery; Drug Resistance, Neoplasm; Gallbladder Neoplasms; Gemcitabine; Leptin; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondrial Dynamics; Myeloid Cell Leukemia Sequence 1 Protein; STAT3 Transcription Factor | 2021 |